Navigation Links
FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
Date:10/18/2007

CHARLOTTESVILLE, Va., Oct. 18 /PRNewswire/ -- Medical Decisions Network (MDN) announces Food and Drug Administration 510(k) clearance for the company's MDN-CGS IV Insulin Dosing Software. The MDN-CGS software is used by hospital nurses to quickly and accurately calculate the dosage of intravenous insulin administered to patients with elevated levels of blood glucose, the simple form of sugar the body converts to energy for survival.

More and more hospitals are adopting measures to control elevated glucose levels (commonly referred to as diabetes or hyperglycemia) in critical care units because studies have shown a resulting marked improvement in patient outcomes. These improvements include reduced mortality (death), length of stay, rate of infection, and a variety of other risks. According to Gary Stouder, MD, at Indiana's Hancock Regional Hospital, "Based on what we've seen so far, by automating our insulin dosing protocol with the MDN-CGS software, we expect to see a decrease in length of stay of 1 day and up to a 50% decrease in mortality in our hyperglycemic ICU patients."

Currently, hospitals rely on printed procedures to calculate IV insulin dosage based on hyperglycemic patients' varying glucose levels. More frequent glucose tests - as many as one or more per hour for tightly controlled ICU patients - burden the already overextended nurses. And referring to complicated paper protocols stresses clinical staff even more. Computerizing these calculations and providing automated patient reports may not only improve glucose control and save critical time and resources, but may reduce potentially dangerous dosing calculation errors as well.

The health benefits of this technology are hard to resist: MDN-CGS users have seen a stark reduction in the incidence of hypoglycemia, a potentially life-threatening severe drop in blood glucose. And it takes significantly less time to get a patient out of the danger zone and into the target glucose range(1).

According to Greg Menke, Medical Decisions Network's CEO, "We've seen technology make sweeping improvements in the quality and cost of healthcare. Our MDN-CGS Computerized Insulin Dosing Software is another major contributor to these improvements because it gives hospital clinicians the power to control hyperglycemia, a huge and growing health and cost burden in this country."

The MDN CGS is a networked application, accessible from any computer on a hospital's network. This means that clinicians can continue a patient's infusion progress even when the patient is moved to a new unit.

"This FDA 510(k) clearance will be important for clinical administrators who are considering the move to this beneficial technology and feel more comfortable with FDA's nod," says Menke. "It's an important step for all of us."

For more information, visit http://www.mdnoutcomes.net.

About Medical Decisions Network

Medical Decisions Network (http://www.mdnoutcomes.net) is an affiliate of Medical Automation Systems, the leader in connectivity solutions for clinical laboratory point-of-care data management, and TEG, Virginia, LLC, an international healthcare research and consulting firm. MDN-CGS is a trademark of Medical Decisions Network.

1. Juneja, Rattan, et al, Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit. Diabetes Technology & Therapeutics. Jun 2007, Vol. 9, No. 3: 232-240.

Contact: Rick Import

Office: (866) 791-6108 x 1017

E-mail: rimport@mdnoutcomes.net


'/>"/>
SOURCE Medical Decisions Network
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Spray on contraceptive clears Phase I trial
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. Cabinet Clears Purchase Preference Policy for Pharma PSUs
6. European Commission Clears Diabetic Insulin for Pregnant Women
7. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
8. FDA Clears Breast Cancer Specific Molecular Prognostic Test
9. FDA Clears Critical Limb-Saving Vascular Device
10. Japanese Expedition Clears Half Ton of Garbage from Mt. Everest
11. Painkilling Patch As Effective As Intravenous Delivery Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: